Oliver Sol

Direttore Tecnico/Scientifico/R&S presso AC IMMUNE SA

58 anni

Health Technology

Consumer Services

Posizioni attive di Oliver Sol

Società	Posizione	Inizio	Fine
AC IMMUNE SA	Direttore Tecnico/Scientifico/R&S	-	-
AC IMMUNE SA	Corporate Officer/Principal	-	-

Società	Posizione	Inizio	Fine
EUROBIO SCIENTIFIC	Direttore Tecnico/Scientifico/R&S	-	-
EUROBIO SCIENTIFIC	Consigliere Generale	-	-
Exonhit Exonhit Pharmaceuticals: MajorHealth Technology Exonhit is developing and manufacturing novel pharmaceuticals from its expertise in the field of alternative RNA splicing, the process by which a single gene can lead to several proteins. The firm's proprietary gene profiling technology DATAS is utilized to identify genes whose splice variants produce abnormal proteins which may trigger or contribute to the development of disease. The company was founded in 1997 and is headquartered in Paris, France.	Direttore Tecnico/Scientifico/R&S	-	-

Distribuzione geografica

Francia	4
Svizzera	2

Posizioni

Chief Tech/Sci/R&D Officer	3
Corporate Officer/Principal	1
General Counsel	1

Settori

Health Technology	4
Consumer Services	2

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	2
AC IMMUNE SA	Health Technology
EUROBIO SCIENTIFIC	Health Technology

Aziende private	2
Exonhit Exonhit Pharmaceuticals: MajorHealth Technology Exonhit is developing and manufacturing novel pharmaceuticals from its expertise in the field of alternative RNA splicing, the process by which a single gene can lead to several proteins. The firm's proprietary gene profiling technology DATAS is utilized to identify genes whose splice variants produce abnormal proteins which may trigger or contribute to the development of disease. The company was founded in 1997 and is headquartered in Paris, France.	Health Technology
Université de Paris XI Paris Sud	Consumer Services

Aziende private

Health Technology

Université de Paris XI Paris Sud

Consumer Services